New Developments
- This forum has 3,260 topics, 1,777 replies, and was last updated 1 year, 8 months ago by .
-
- Topic
- Voices
- Last Post
-
- ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable
- 1
- 3 years, 7 months ago
- Clinicopathological features and recurrence patterns of combined hepatocellular-
- 1
- 3 years, 7 months ago
- Therapy for advanced cholangiocarcinoma: Current knowledge and future potential
- 1
- 3 years, 7 months ago
- Serum IgG as a Marker for Opisthorchis viverrini-Associated Cholangiocarcinoma C
- 1
- 3 years, 7 months ago
- CD40-mediated immune cell activation enhances response to anti-PD1 in murine int
- 1
- 3 years, 7 months ago
- Sixth Cranial Nerve Palsy as the Presenting Sign of Metastatic Cholangiocarcinom
- 1
- 3 years, 7 months ago
- Clinical practice guidelines for the management of biliary tract cancers 2019: t
- 1
- 3 years, 7 months ago
- Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Bil
- 1
- 3 years, 7 months ago
- Machine learning: an approach to preoperatively predict PD-1/PD-L1 expression an
- 1
- 3 years, 7 months ago
- Anti-tumour effect of the fourth-generation chimeric antigen receptor T cells ta
- 1
- 3 years, 7 months ago
- Intrahepatic cholangiocarcinoma: MRI texture signature as predictive biomarkers
- 1
- 3 years, 7 months ago
- The forum ‘New Developments’ is closed to new topics and replies.